Uncovering the role of microRNAs in response to interferon-beta therapy among multiple sclerosis patients: A

Mitra Pourseirafi1, Seyed Reza Mousavi1, Anoosha Niazmand2

  • 1Cellular, Molecular and Genetics Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Abstract

Insights

MicroRNAs (miRNAs) significantly impact interferon-beta (IFN-β) treatment response in multiple sclerosis (MS). Identifying these miRNAs could lead to personalized MS therapies.

Area of Science:

  • Neuroimmunology
  • Genetics
  • Pharmacogenomics

Background:

  • Multiple sclerosis (MS) is a common neurodegenerative disorder affecting young adults.
  • Interferon-beta (IFN-β) is a standard MS treatment, but patient responses vary widely.
  • MicroRNAs (miRNAs) are increasingly recognized for their role in immune responses and treatment variability.

Purpose of the Study:

  • To systematically review the role of miRNAs in the efficacy, response, and mechanisms of IFN-β therapy in MS patients.
  • To identify specific miRNAs associated with IFN-β treatment outcomes in MS.
  • To explore the molecular pathways influenced by miRNAs in the context of IFN-β therapy.

Main Methods:

  • Systematic review adhering to PRISMA guidelines, searching major databases up to 2025.
  • Inclusion of studies on miRNA expression in relapsing-remitting MS (RRMS) patients comparing responders to non-responders.
  • Weighted vote-counting synthesis for miRNA significance, followed by target prediction, network construction (miRNA-target, PPI), and pathway enrichment analysis.

Main Results:

  • 13 studies analyzed, reporting on over 184 miRNAs related to IFN-β therapy.
  • Significantly dysregulated miRNAs identified include miR-29b, miR-504, miR-185-5p, and miR-27a.
  • Pathway analysis revealed involvement of miRNAs and hub genes in immune regulation, interferon signaling, and neuroinflammation.

Conclusions:

  • Findings highlight miRNA-mediated mechanisms influencing IFN-β treatment in RRMS.
  • Identified miRNAs and pathways offer potential for developing targeted and personalized MS treatment strategies.
  • This review provides insights into optimizing IFN-β therapy efficacy through a miRNA-centric approach.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...